NEW: WHO temporarily halts trial of hydroxychloroquine over safety concerns.
"The executive group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity trial while the safety data is reviewed by the data safety monitoring board. The other arms of the trial are continuing,” Tedros told an online briefing.
Dr. Soumya Swaminathan, WHO's chief scientist, said the organization's own investigators and regulators in individual nations have raised enough red flags about hydroxychloroquine to prompt this halt. "So the steering committee met over the weekend and decided that in the light of this uncertainty, that we should be proactive, err on the side of caution, and suspend enrollment, temporarily, into the hydroxychloroquine arm," she said.David K. Li is a breaking news reporter for NBC News.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WHO temporarily pauses studying hydroxychloroquine due to safety concernsThe coronavirus pandemic has brought countries to a standstill. Here's the latest updates on Covid-19 cases, deaths, government responses and more.
Read more »
Trump says he's finished hydroxychloroquine regimen to ward off COVID-19The FDA has cautioned against the use of hydroxychloroquine and chloroquine for COVID-19 treatment outside of hospitals or clinical trials.
Read more »
Trump says he’s no longer taking hydroxychloroquine“Finished, just finished,” the president said of the unproven treatment he'd said he was taking to protect himself from the coronavirus. “And by the way, I’m still here.”
Read more »
Veterans Affairs Gives 1,300 Vets Unproven COVID-19 Drug Touted By TrumpHydroxychloroquine has not been shown to be effective against the coronavirus and may even lead to fatal side effects.
Read more »
Hydroxychloroquine in short supply, says FDA. 'Angry, disappointed and scared,' say lupus patients.Trump touted hydroxychloroquine use against COVID-19 in March. Now, the FDA says there's a shortage and lupus patients say they're the ones suffering.
Read more »